To support future growth and production expansions, Novo Nordisk Pharmatech has invested in a new plot of land close to headquarters in Køge Nord (North).
The land is 47.000 square meters and is located less than two kilometers from the existing site in Køge Nord. With the purchase, the needed space for future expansions is ensured while maintaining the synergies with the nearby headquarters and the interaction with local authorities.
“For the past six months, we have been looking for a suitable location for our new production facility. Køge Nord is an obvious choice due to the proximity to our existing headquarters and the good infrastructure around Køge,” explains Ulla Grove Krogsgaard Thomsen, CEO of Novo Nordisk Pharmatech. “We are creating 50 new jobs in connection with establishing the new facility, and there are good opportunities to expand production even more in the future.”
Marie Stærke, the mayor of Køge Municipality, shares:
“I am happy that a high-profile Danish company like Novo Nordisk Pharmatech chooses to expand its presence here in Køge Municipality. We would like to develop on the business front by attracting new types of sustainable and innovative production companies within, for example, the technology, food, or pharmaceutical industry – so also in that light, Novo Nordisk Pharmatech is an excellent buyer of the large commercial plot with the good location in Køge Nord.”
The precise intended use of the property will be communicated at a later date.